All bacterial infections occur within a polymicrobial environment, from which a pathogen population emerges to establish disease within a host. Emphasis has been placed on prevention of pathogen dominance by competing microflora acting as probiotics 1 . Here we show that the virulence of the human pathogen Staphylococcus aureus is augmented by native, polymicrobial, commensal skin flora and individual species acting as 'proinfectious agents'. The outcome is pathogen proliferation, but not commensal. Pathogenesis augmentation can be mediated by particulate cell wall peptidoglycan, reducing the S. aureus infectious dose by over 1,000-fold. This phenomenon occurs using a range of S. aureus strains and infection models and is not mediated by established receptor-mediated pathways including Nod1, Nod2, Myd88 and the NLPR3 inflammasome. During mouse sepsis, augmentation depends on liver-resident macrophages (Kupffer cells) that capture and internalize both the pathogen and the proinfectious agent, leading to reduced production of reactive oxygen species, pathogen survival and subsequent multiple liver abscess formation. The augmented infection model more closely resembles the natural situation and establishes the role of resident environmental microflora in the initiation of disease by an invading pathogen. As the human microflora is ubiquitous 2 , its role in increasing susceptibility to infection by S. aureus highlights potential strategies for disease prevention.
deficient in an amino acid permease and a global regulator of virulence factors 10, 11 ) of S. aureus SH1000 is able to augment infection caused by a low dose of a virulent strain ( Fig. 1a ). Only the low-dose virulent organism substantially benefits ( Supplementary Fig. 1a ). To test if unrelated non-pathogenic organisms can similarly augment infection, the skin commensal Micrococcus luteus was co-injected with S. aureus (Fig. 1b ). M. luteus alone does not cause disease and is swiftly eliminated from the host when injected alone or in combination with S. aureus ( Fig. 1c and Supplementary Fig. 1b ). However, its presence significantly enhances S. aureus virulence, leading to host mortality and pathogen proliferation. Both pathogen and commensal can be found co-localized in phagocytes in vivo ( Fig. 1d ), characteristic of S. aureus infection dynamics in this model.
S. aureus infection of humans is often iatrogenic, resulting in co-inoculation of skin (or other) microflora. The ability of human skin commensal organisms to augment S. aureus mammalian infection was next tested. Staphylococcus epidermidis or M. luteus at 1-2 × 10 8 colony-forming units (c.f.u.) led to augmentation ( Fig. 1e-h) . Survival of S. epidermidis was not enhanced by S. aureus, and M. luteus was completely cleared (Fig. 1f ). M. luteus at 1 × 10 8 c.f.u. could augment as low as 1 × 10 5 c.f.u. S. aureus ( Supplementary Fig. 1c ). Combining 1 × 10 6 c.f.u. of both S. aureus and M. luteus gave a significant increase in S. aureus liver c.f.u. ( Supplementary Fig. 1d ). Live commensal flora, while able to augment infection, are cleared by the host, probably because they do not have the multiple mechanisms that enable S. aureus to avoid killing by the innate immune system 12, 13 . The number of commensal bacteria necessary to augment S. aureus infection is comparable to that found on the skin, where punch biopsies have demonstrated at least 1 × 10 6 c.f.u. cm −2 (ref. 14 ) . Also in a study of vascular catheters, a range of bacteria were found with numbers up to 1 × 10 7 c.f.u. (ref. 15 ). However, it was important to demonstrate the ability of the natural mix of mammalian skin microflora to augment pathogenesis. Thus, skinassociated microbiota containing material from either naturally colonized or GF mice was harvested and used directly to augment S. aureus infection. Pathogenesis of S. aureus could be augmented by material from mice colonized with native microflora, whereas Letters NATuRE MicRobioLogy material from germ-free (GF) mice could not ( Fig. 1i , P < 0.05). This demonstrates that native flora has the capacity to augment S. aureus infection. Given the varied molecular moieties that can augment infection, we have named them 'proinfectious agents' .
To determine the molecular basis of proinfectious agents we first established that heat-killed M. luteus can augment zebrafish infection, strongly suggesting a bacterial cellular component may be responsible (Fig. 1b ). Peptidoglycan (PGN) is a bacterial cell wall polymer, known to have many host immune system interactions 16, 17 . Particulate, but not soluble, M. luteus PGN can augment infection and is co-localized within phagocytes with S. aureus (Fig. 2a-c and Supplementary Fig. 1e ). Latex beads are also co-phagocytosed but do not alter the infection dynamics or outcome ( Supplementary  Fig. 1f -i and Supplementary Video 5), demonstrating that this is not a simple niche-filling phenomenon. PGN as a proinfectious agent was then tested in the murine sepsis model of infection, where a mixed inoculum consisting of S. aureus NewHG (low-dose, 1 × 10 6 c.f.u.) and M. luteus PGN (500 μ g) was injected intravenously (i.v.) and compared to each component alone. PGN alone had no effect on animal weight or health status ( Supplementary Fig. 2a ). Mice receiving the mixed inoculum lost significantly more weight than low-dose controls (P < 0.001), with exceedingly high S. aureus numbers (~1 × 10 8 c.f.u.) recovered from livers ( Fig. 2d,e ). Only mixed inocula caused severe structural deterioration of liver parenchyma, including multiple, small abscesses ( Fig. 2f ). At 72 h post infection (h.p.i.), in the presence of PGN, classical abscesses were formed where a central extracellular nidus of S. aureus is surrounded by a dense neutrophilic infiltrate. Solubilized PGN and latex beads did not augment infection (Fig. 2d,e and Supplementary Fig. 2b-d) . PGN augmented infection with the community-acquired methicillin-resistant S. aureus (MRSA) strain JE2 (Supplementary Fig. 2e-g) , leading to increased kidney c.f.u. and weight loss. As the augmentation phenomenon has been demonstrated with three distinct strains, ranging from laboratory to emergent clinical epidemic strains 18 , and including both methicillin-sensitive (MSSA) and methicillin-resistant (MRSA) strains, it is inferred that strain specificity does not play a significant role.
Large inocula are required to reliably establish infection in S. aureus murine models, with 1 × 10 7 to 1 × 10 8 c.f.u. injected as standard [19] [20] [21] . It is improbable that such large doses are mirrored in human infection, and early work notes that "a nasal droplet 100 μ m in diameter could not accommodate this number, even if it consisted entirely of staphylococci" 22 . However, the S. aureus infectious dose can be drastically reduced when augmented with PGN. Significant weight loss occurred with a dose of S. aureus as low as 1 × 10 5 c.f.u. in the co-inoculum ( Supplementary Fig. 2h ) and, strikingly, high liver bacterial numbers were recovered from all mice receiving 1 × 10 4 c.f.u. (Fig. 2g ). Astonishingly, one mouse exhibited a liver burden of 1 × 10 6 c.f.u. with an inoculum of only 700 c.f.u. A lower PGN dose of 250 μ g also led to augmentation ( Fig. 2h and Supplementary Fig. 2a ).
To determine how augmentation enhances disease outcome, S. aureus population dynamics during infection were evaluated. We have previously identified a phagocyte-dependent immunological bottleneck, from which clonal expansion of a small number of bacteria results in characteristic kidney abscesses 8 . Mice were injected with three marked but otherwise isogenic S. aureus strains in a 1:1:1 ratio totalling 1 × 10 6 c.f.u. At 30 min post-infection, regardless of PGN addition, the majority of the c.f.u.s were in the liver; without PGN, bacterial numbers subsequently declined ( Fig. 2i ). As infection progressed there were significantly more S. aureus in the liver, kidneys and spleens of mice receiving mixed inocula. To understand clonal expansion in this context, we assessed the contribution to the final bacterial load of the three marked strains, in each organ. By 70 h.p.i., dominance by individual or pairs of strains indicated clonal expansion in kidneys, but less so in the liver ( Fig. 2j and Supplementary Fig. 2k ,l). However, careful dissection and bacterial enumeration of individual liver abscesses showed that these were clonal ( Fig. 2j ; P < 0.001).
To determine the molecular basis for infection augmentation, PGNs from a range of species including Staphylococcus epidermidis, Curtobacterium flaccumfaciens, Bacillus subtilis and S. aureus strains were used. Infection could be augmented in the murine sepsis model by PGN from all species tested ( Supplementary  Fig. 3a-l) , with a diversity of amino acids in the peptide side chain, suggesting the conserved glycan moiety is important. C. flaccumfaciens has unusual PGN for a Gram-positive organism as it contains glycine as the first peptide in the side chain as opposed to l-alanine. B. subtilis PGN contains meso-diaminopimelic acid (m-DAP) at stem peptide position 3, an amino acid commonly found in the PGN of Gram-negative bacteria 23 . PGN from S. epidermidis, however, is similar to that of S. aureus, the only difference being altered composition of the crosslinking side chains. The presence of wall teichoic acids on PGN (that is, the PGN was not hydrofluoric acid treated) did not alter augmentation ( Supplementary Fig. 3m -o). S. aureus lipoproteins are immunostimulatory via TLR2 24 ; however, PGN from a lipoprotein-deficient mutant (lipoprotein diacylglyceryl transferase, lgt) could still augment pathogenesis ( Supplementary  Fig. 3p -r). Furthermore, solubilization of PGN abrogates augmentation, eliminating a contaminating moiety within the preparations as the mechanism of augmentation. PGN can also augment infection in other murine models. Using S. aureus LS-1 and NMRI mice, M. luteus PGN caused increased severity in both septic arthritis ( Fig. 2k ,l) and subcutaneous abscess models ( Supplementary  Fig. 4a ,b) in which PGN alone had no effect.
Augmentation circumvents the immune bottleneck during pathogenesis that we have hypothesized occurs inside phagocytes 8, 9 (Fig. 2c ). Therefore, we depleted either neutrophils or macrophages (and macrophage-like cells) before challenge in the murine sepsis model. Depletions led to an expected increased susceptibility to S. aureus, thus requiring a reduced inoculum of 1 × 10 5 c.f.u. Macrophage depletion using clodronate liposomes resulted in multiple, small liver abscesses reminiscent of PGN augmentation. However, addition of PGN to the inoculum did not lead to augmentation, suggesting a critical role for macrophages (or related cells) in augmentation of pathogenesis ( Fig. 3a) . Conversely, infection of neutropenic mice was still PGN augmented ( Fig. 3b ), and this is in agreement with in vitro data where co-incubation of S. aureus and PGN with human-derived neutrophils did not promote survival of S. aureus compared to bacteria only controls ( Supplementary  Fig. 4c ). However, survival of intracellular S. aureus in human monocyte derived macrophages (MDMs) was increased in the presence of PGN (Supplementary Fig. 4d ; P < 0.01), demonstrating a potential human relevance for our findings.
Augmentation of infection by PGN leads to liver abscesses, so to decipher the organ-and cellular-level mechanisms, we used spinning-disk intravital microscopy (SD-IVM) to visualize Kupffer cells (KCs; liver-resident macrophages) and other innate immune cells. Polymorphonuclear neutrophils (PMNs) are crucial for S. aureus control by the host in both animal models 25, 26 and humans 27 . Additionally, an important role for KCs in capturing and eliminating S. aureus during bacteraemia has been described recently 19, 28 . Fluorescently labelled PGN and S. aureus-GFP were co-injected into C57BL/6J mice and both were rapidly engulfed by KCs (purple), but not neutrophils (red) ( Fig. 3c and Supplementary Videos 1 and 2). The rate of S. aureus capture by KCs was not perturbed by PGN augmentation ( Fig. 3d ). However, at 8 h.p.i., mice receiving mixed inocula had significantly more S. aureus-GFP within the liver than controls, and by 24 h.p.i. they contained small, multilobar focal abscesses ( Fig. 3e ), concomitant with an elevated S. aureus burden ( Fig. 3f ). Augmentation with PGN did not affect neutrophil recruitment Letters NATuRE MicRobioLogy at 8 h.p.i. (Fig. 3g ), but by 24 h.p.i. there was a significant increase ( Fig. 3g ), consistent with abscess formation (Figs. 2f and 3e). These data suggest that a mixed inoculum leads to inadequate control of S. aureus inside KCs.
It has been previously shown that during natural colonization of mice an immune tolerance to S. aureus infection occurs, mediated by Nod1 29 . To test whether prior exposure to commensal organisms affects augmentation, we tested the phenomenon in germ-free (GF) mice, which are incidentally more susceptible to S. aureus 30 . Using SD-IVM it was observed that the rate of staphylococcal capture by KCs is comparable to that seen in wild-type mice and, importantly, S. aureus pathogenesis is augmented by particulate PGN ( Supplementary Fig. 4e -g).
Host PGN recognition has been attributed to TLR2 receptors, but this is now known to be due to lipoprotein contamination 31 . We demonstrated no role for MyD88-dependent signalling in augmentation and also ruled out the cytosolic PGN receptor Nod2 and the NLRP3 inflammasome ( Fig. 4a,b ). Furthermore, the range of PGN structures able to augment precluded a role for Nod1 32 and the NLRP3 inflammasome 33 ( Supplementary Fig. 3a -l). However, Cybb −/− mice, missing the NADPH oxidase 34 required by phagocytes to produce reactive oxygen species (ROS), showed a lack of augmentation at 8 h.p.i. (Fig. 4b ). Cybb −/− mice are highly susceptible to S. aureus infection ( Fig. 4b) , not surviving beyond 24 h.p.i. At a lower inoculum of 1 × 10 5 c.f.u., 8 h.p.i. imaging was not possible due to low fluorescence levels, but at 24 h.p.i., augmentation was still not observed ( Fig. 4c ), confirming the likely mechanistic involvement of ROS. Augmentation with PGN led to greatly diminished oxidation (P < 0.0001) and to less acidification (P < 0.01) of the phagolysosomes containing S. aureus in KCs ( Fig. 4d-f and Supplementary Videos 3 and 4), highlighting the critical role of ROS.
A characteristic feature of many S. aureus infection models is a high inoculum. Here we have established that the majority of the infecting material can be commensal bacteria or even cell wall PGN. 
Letters

NATuRE MicRobioLogy
of the pathogen to initiate infection. Pseudomonas aeruginosa is known to respond to PGN to enhance its virulence 37 . As well as at the initiation of infection, augmentation could occur during the action of antibiotics, where death of a proportion of the bacterial population may give rise to cell wall fragments. Also, indwelling medical devices, such as intravascular catheters, reside in situ for several days, and the prosthetic material can become colonized by commensal flora 15 . As catheters are regularly accessed, both commensal flora (for example, M. luteus and S. epidermidis) and pathogen (S. aureus) could be flushed into the bloodstream simultaneously. Our work establishes a precedent for how a human pathogen can initiate disease using proinfectious agents, as microbial crowdsourcing to circumvent immune system control. In clinical practice, infection by all bacterial pathogens occurs from within a microflora and is therefore initially polymicrobial. This raises the likelihood of a more general role for proinfectious agents, requiring revision of existing models of bacterial pathogenesis and highlighting the involvement of commensal organisms as unwitting accomplices in infection initiation.
Methods
Bacterial strains and culture conditions. S. aureus, M. luteus, C. flaccumfaciens and S. epidermidis strains ( Table 1) were grown using brain heart infusion (BHI) liquid or solid medium (Oxoid) at 37 °C, with the exception of M. luteus which was grown at 30 °C. Bacillus sp. strains were grown using nutrient agar liquid or solid 
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NATuRE MicRobioLogy medium (Oxoid) at 37 °C. Supplementation with the following antibiotics was added where appropriate: kanamycin 50 µ g ml −1 , tetracycline 5 µ g ml −1 or erythromycin 5 µ g ml −1 plus lincomycin 25 µ g ml −1 (Sigma-Aldrich).
To distinguish bacterial populations in mixed inocula experiments, M. luteus was serially passaged on BHI medium with or without rifampicin (0.03 μ g ml −1 ) and incubated at 30 °C until a rifampicin-resistant derivative was identified. The same procedure was carried out for S. epidermidis. For all murine experiments, pregrown batches of bacteria were thawed, washed and diluted to the desired concentration in endotoxin-free PBS (Sigma). Staining of bacterial cells for microscopy was carried out as described for PGN below (see section 'Preparation of latex beads, peptidoglycan and bioparticles'). SH1000 mCherry and SH1000 GFP were constructed as follows. The pMV158mCherry plasmid was constructed by introducing a gene encoding mCherry (Uniprot: X5DSL3-1) into pMV158GFP 38 and replacing the existing GFP gene. The plasmids, pMV158GFP and pMV158mCherry, were then introduced into S. aureus RN4220 by electroporation, resulting in transformants expressing GFP and mCherry, respectively. The plasmids were subsequently transferred into S. aureus SH1000 by Φ 11 transduction and the obtained transductants were verified by fluorescence microscopy. To create an avirulent S. aureus mutant, SH1000pheP 11 (deficient in amino acid permease) was transduced into SH1000saeR 39 (mutation affecting the two-component system required for innate immune evasion) using Φ 11 phage. The same phage was used to transduce lgt::ermB from S. aureus SA113 background into SH1000.
Preparation of latex beads, peptidoglycan and bioparticles.
For in vivo latex bead experiments, polystyrene latex beads (1.1 μ m, Sigma) were washed in endotoxin-free PBS, diluted to the desired concentrations and sonicated for 3 × 30 s (Soniprep 150, MSE) before injection into infection models. To prepare PGN, a mid-exponential phase bacterial culture was prepared in appropriate medium and purification was carried out as previously described 40 . Endotoxin assay was carried out using Pyrochrome (Associates of Cape Cod) according to the manufacturer's instructions. No significant difference in endotoxin concentration was detected between enzyme-only control and the various solubilized Gram-positive PGN preparations. To solubilize PGN, 250 μ g ml −1 mutanolysin (50 mM sodium phosphate buffer, pH 5.5) was added and incubated at 37 °C overnight on a rotary shaker (100 r.p.m.). Thereafter, the mixture was heated to 95 °C for 5 min before being centrifuged (13, Letters NATuRE MicRobioLogy consent, in compliance with the guidelines of the South Sheffield Research Ethics Committee (07/Q2305/7). Neutrophils were purified from anticoagulated human blood as previously described 41 . In triplicate and with two biological repeats, ~2.5 × 10 6 cells per ml were co-incubated at 37 °C with S. aureus NewHG bacteria to produce a multiplicity of infection (MOI) of 5 in the presence or absence of M. luteus PGN. At 30 and 90 min post co-culture, extracellular and intracellular c.f.u.s were calculated. To measure intracellular c.f.u.s, the co-culture was transferred to a microcentrifuge tube, centrifuged at 2,000 r.p.m. for 2 min, before the supernatant was removed. The neutrophils were then lysed with 1% (wt/vol) saponin for 10 min at room temperature (RT). Bacterial enumeration was calculated from serial dilutions. At 90 min, lysostaphin (20 μ g ml −1 ) was added to the remaining co-culture wells for 30 min to lyse extracellular bacteria for the final 120 min time point.
Phagocyte bacterial challenge and quantification of viable intracellular bacteria. Human blood was obtained from healthy volunteers, with informed
MDMs were isolated from peripheral blood mononuclear cells (PBMCs) from healthy donors, as previously described 42 . PBMCs were isolated by Ficoll Plaque (GE Healthcare) density centrifugation, seeded at 2 × 10 6 cells per ml in RPMI 1640 medium with 2 mmol l −1 l-glutamine (Lonza) supplemented with 10% vol/vol newborn fetal calf serum (Gibco) in 24-well plates (Corning) with 1 ml per well to achieve approximately 2 × 10 5 MDMs per ml. After 24 h, non-adherent cells were removed and adherent cells were cultured in RPMI 1640 medium with 2 mmol l −1 l-glutamine supplemented with 10% vol/vol low-endotoxin heat-inactivated fetal calf serum (Biosera) and used at 14 days. Differentiated MDMs were challenged with S. aureus NewHG at an MOI of 0.5. The bacteria were thawed, washed in PBS and added to the MDMs in fresh medium. M. luteus PGN (sonicated for 3 × 30 s bursts) was added to the bacteria-containing medium at a concentration of 100 μ g ml −1 . The MDMs were incubated on ice for 1 h then at 37 °C in 5% vol/vol CO 2 . Following a 4 h total challenge, infected medium was removed and the MDMs were washed with ice cold PBS. Residual extracellular bacteria were killed by addition of 100 μ g ml −1 gentamicin in fresh medium and incubated for 30 min, then maintained in medium containing 20 μ g ml −1 of gentamicin (Sanofi-Aventis) until the desired time point. MDMs were washed with PBS and incubated with 2% vol/vol saponin (Sigma) at 37 °C for 12 min. PBS was added and cells were lysed by scraping and pipetting. Estimation of viable intracellular bacteria was determined by a surface viable count 6 . To confirm complete killing of extracellular bacteria, some wells were fixed with 2% vol/vol paraformaldehyde before bacterial challenge, then exposed to gentamicin and lysed as described, demonstrating absence of bacteria in lysates. Intracellular killing after initial bacterial challenge was estimated by lysing cells maintained in 20 μ g ml −1 of gentamicin for 0.5-3.5 h.
Animal experiments. Murine work was carried out according to UK law in the Animals (Scientific Procedures) Act 1986, under Project Licence PPL 40/3699, approved by the Animal Research Ethical Committee of Gothenburg or approved by the University of Calgary Animal Care Committee (AC12 0162) in compliance with the Canadian Council for Animal Care Guidelines.
Murine models. All mice ( Table 2) were housed in designated animal facilities in standard environmental conditions of temperature and light and fed laboratory chow and water ad libitum. For the haematogenous septic arthritis model, S. aureus LS-1 43 was inoculated i.v. into the tail vein female of NMRI mice (n = 10), 6-8 weeks old (Charles River Laboratories) with 0.2 ml of low-dose LS-1 (1 × 10 6 c.f.u.), with or without 1 mg M. luteus PGN. Mice were regularly weighed and examined for clinical arthritis by observers blinded to the groups as previously described 44 . In brief, a clinical scoring system ranging from 0 to 3 was used for each paw (0, no inflammation; 1, mild visible swelling and/or erythema; 2, moderate swelling and/or erythema; 3, marked swelling and/or erythema). The clinical arthritis severity overall score was constructed by adding the scores from all four limbs for each animal. On day 10, mice were killed and limbs were resected for microcomputed tomography (micro-CT) radiological examination of bone erosion.
For the staphylococcal skin infection model, NMRI mice (n = 18) were anaesthetized with ketamine/medetomidine and the dorsum was shaved before subcutaneous (s.c.) injection of one flank with 0.05 ml of S. aureus SH1000 (1 × 10 6 c.f.u. per spot) and a mixture of SH1000 (1 × 10 6 c.f.u. per spot) with PGN (250 µ g per spot) in the other flank. PGN alone did not cause any inflammation or skin lesions. Two observers blinded to the treatment groups measured the lesion size of each mouse with a caliper on day 4. The skin lesion was measured using the mathematical formula for the area of an ellipse. After euthanizing the mice on day 4, skin was disinfected with 70% vol/vol ethanol and skin biopsies encompassing the entire infected area were taken with a sterile 8 mm biopsy puncher (Kai Medical, Seki). Biopsy samples were homogenized (Ultra Turrax T25 homogenizer) and viable counts of bacteria were assessed 45 .
For the mouse sepsis model, female BALB/c mice (Charles River Laboratories) or male and female C57BL/6 mice at 7-8 weeks of age (Jackson Laboratory) were inoculated in the tail vein with 0.1 ml S. aureus (NEWHG or JE2), M. luteus or S. epidermidis either alone (dose range 1 × 10 2 to 1 × 10 7 c.f.u. as indicated) or with PGN (50 µ g to 1 mg as indicated) or with PGN only. Mice were monitored and euthanized at 72 h.p.i. unless otherwise stated or according to experimental design. Mouse organs were individually homogenized in PBS and, after serial dilution, plated onto BHI agar supplemented with antibiotics as needed for bacterial number enumeration. GF and C57BL/6(J) mice were bred and maintained in flexible-film isolators or in individually ventilated cages at the Clean Mouse Facility, University of Bern. At the age of 6 weeks these mice were shipped under GF conditions to the University of Calgary. Alternatively, GF mice were obtained from Taconic. GF status was routinely monitored by culture-dependent and -independent methods and all mice were independently confirmed to be pathogen-free.
For the dermonecrosis model, mice were left in their cage without changing the bedding material for at least 7 days. Mice were euthanized and skin samples (2 cm 2 ) were surgically removed from the abdominal region of specific pathogenfree (SPF) C57BL/6J or GF mice. Isolation of skin microorganisms was performed by incubation of the skin samples in PBS containing 0.1% Triton X-100 for 1 h at 37 °C under high agitation. Skins were gently massaged against a 100 µ m filter with additional PBS-Triton. Isolated microorganisms were centrifuged and washed 3× with PBS and stored on ice until the infection experiment. Skin microbes were enumerated by culturing on tryptic soy blood agar plates for 48 h at 25 °C. At 24 h before infection experiments, hair from the dorsal region of C57BL/6J mice was removed by shaving and hair removal cream (Nair). The left dorsal flank of each mouse was subcutaneously injected with 1 × 10 7 c.f.u. S. aureus (injection volume 50 µ l) and the right dorsal flank received a co-injection of the isolated skin microbes and 1 × 10 7 c.f.u. S. aureus. At 48 h.p.i. mice were euthanized and skin lesions were photographed. The dermonecrotic lesion area was measured using ImageJ.
For SD-IVM experiments, a tail vein catheter was inserted into mice after anaesthetization with 200 mg kg −1 ketamine (Bayer Animal Health) and 10 mg kg −1 xylazine (Bimeda-MTC). Surgical preparation of the liver for intravital imaging was performed as previously described 46 . Mouse body temperature was maintained at 37 °C with a heated stage. Image acquisition was performed using an Olympus IX81 inverted microscope, equipped with an Olympus focus drive and a motorized stage (Applied Scientific Instrumentation) and fitted with a motorized objective turret equipped with × 4/0.16 UPLANSAPO, × 10/0.40 UPLANSAPO and × 20/0.70 UPLANSAPO objective lenses and coupled to a confocal light path (WaveFx; Quorum Technologies) based on a modified Yokogawa CSU-10 head (Yokogawa Electric Corporation). Target cells were visualized using fluorescently stained antibodies or fluorescent reporter bacteria. Typically, KCs and neutrophils were stained by i.v. injection of 2.5 µ g anti-F4-80 or 3.5 µ g anti-ly6G fluorescent conjugated monoclonal antibodies (mAbs). Laser excitation wavelengths of 491, 561, 642 and 730 nm (Cobolt) were used in rapid succession, together with the appropriate bandpass filters (Semrock). A back-thinned electron-multiplying charge-coupled device 512 × 512 pixel camera was used for fluorescence detection (Hamamatsu). Volocity software (Perkin Elmer) was used to drive the confocal microscope and for 3D rendering, acquisition and analysis of images. For quantification of staphylococcal catching or measurements of bioparticle oxidation and acidification in the liver, five random FOVs with × 10 objective were selected before injection of bacteria. Fluorescent reporter bacteria or reporter bioparticles were injected i.v. into mice 1 min after initiation of acquiring background images. The 'find objects' function in Volocity software was used to identify individual captured bacteria or bioparticles by KCs (F4/80 + cells in liver) and when appropriate autofluorescent spots were subtracted from the final quantification. For bioparticles the particles were selected in the AF647 reference channel and an increase in pHrodo (acidification) and OxyBURST (oxidation) fluorescence was quantified in the first hour after infection. For quantification of SD-IVM images, at 4 h.p.i., computer-generated stitched images (2 mm 2 ) were generated using the stitched image function in Volocity. Volocity software was also used to quantify relative GFP fluorescence as a measure of the presence of S. aureus-GFP or tdTomato for the quantification of neutrophils in the liver after staphylococcal infection. SD-IVM images of uninfected mice were used to determine the background fluorescence, and S. aureus-GFP was quantified with the same settings for all mutants and treatments.
Macrophage and neutrophil depletion. Macrophages were depleted using clodronate liposomes (NvR). The mice were injected i.v. with 1 ml of liposomes per 100 g on day 1 according to the manufacturer's instructions. The mice were then injected with 1 × 10 5 c.f.u. of S. aureus NewHG (1:1:1 mixture of NewHG Ery R , Tet R or Kan R ) on day 2. Blank liposomes were used as a control. Macrophage depletion was confirmed using histology sections of the liver stained with anti-macrophage antibody (rat anti-mouse F4/80, AbD Serotec, cat. no. MCA497R). For antibodybased neutrophil depletion, in vivo anti-ly6G mouse antibody (1A8, BioXcell, cat. no. BE0075-1) was used according to the previously published protocol 47 . The mice were injected with 1.5 mg of antibody per mouse (200 µ l per mouse) on day 1, with the mice being injected with 5 × 10 5 c.f.u. S. aureus NewHG (1:1:1 mixture of NewHG Ery R , Tet R or Kan R ) on day 2. A 100 µ l volume of blood was collected via tail bleeding at the time of S. aureus injection and at the end of the experiment via terminal anaesthesia and heart puncture. The blood samples were mixed with 20 µ l of heparin each and then stained with APC rat anti-mouse Ly-6G antibody (BD Biosciences, cat. no. 560599) according to the BD Bioscience protocol. The samples were then processed using the BD LSRII flow cytometer to confirm neutrophil depletion.
Histological analysis of mouse organs. Histological analysis was carried out within a liquid nitrogen dewar; individual organs were placed in an embedding Letters NATuRE MicRobioLogy cube, partially pre-filled with optimal cutting temperature (OCT) medium. Ensuring the correct positioning for optimal sectioning, the remaining cube was filled with medium and stored at − 80 °C. Pre-sectioning, organs were stored at − 20 °C, and 200 μ m slices were taken before staining with haematoxylin and eosin (H&E) stain, as previously established 39 .
Zebrafish model. Zebrafish embryos less than 5 days post fertilization (d.p.f.) are not protected under the Animals (Scientific Procedures) Act 1986 but all zebrafish work was carried out according to the details set out in Project License PPL 40/3574.
For zebrafish experiments, London wild-type (LWT) embryos were incubated in E3 medium at 28 °C according to standard protocols 48 . Embryos were microinjected at 30 h post fertilization (h.p.f.) into the circulation valley as previously described 10 . Following injection, embryos were kept individually in 100 µ l E3 medium and survival was recorded for up to 90 h.p.i. For bacterial growth experiments in vivo, at various time points, embryos were collected and bacterial numbers were enumerated as described for mouse organs.
For microscopy, live anaesthetized zebrafish were mounted onto 15 mm Petri dishes in 1% (wt/vol) low-melting-point agarose and E3 solution. Images were acquired using either the TE-2000U microscope (Nikon) with a Hamamatsu Orca-AG camera (objectives used: × 4 Nikon Plan Fluor objective NA 0.13 and × 60 Nikon Plan Apo oil objective NA 1.4; fluorophores excited with either 488 nm (GFP) or 543 nm (mCherry)) or the UltraVIEW VoX spinning-disk confocal microscope (Perkin Elmer) (GFP, mCherry and Alexa Fluor 647 were excited by a 457-451 nm argon laser, 561 nm sapphire laser and 642 nm diode laser, respectively). Image acquisition and processing were performed with Volocity software.
Statistical analysis. Sample sizes were predetermined for mouse and zebrafish experiments based on previous experimental data 8, 10 . The refined murine sepsis model, augmenting S. aureus sepsis with PGN, increased reproducibility and decreased the spread of results. Revised power calculations (80% power; 95% confidence) permitted comparisons with five animals per group (n = 5) for both weight loss (10% difference) and liver c.f.u. (2log difference). Animal experiments were not blinded, but, to reduce bias, selected experiments were performed by different team researchers. Mice were randomly selected for experimental or control groups and kept in separate cages throughout the experiment. In instances of unexpected death in animals that had otherwise been showing normal health, animals were excluded from analysis as per pre-established criteria. All statistical tests were appropriate for the type of data obtained. For zebrafish embryo survival experiments, the Kaplan-Meier method was applied. A comparison between survival curves was made using the log-rank (Mantel-Cox) test. For bacterial count comparison, skin lesion size or clinical arthritis severity in murine experiments, the Mann-Whitney U and Wilcoxson signed rank tests were used for comparison of unpaired and paired data, respectively. For comparison of two or more independent samples (parametric) a one-way ANOVA was used with Tukey's multiple comparison test. A two-way repeated measurements ANOVA compared pHrodo and OxyBURST data as shown and the c.f.u. quantification in neutrophils. For macrophage assays, a two-way ANOVA with Tukey's multiple comparison post-test was used between the first two time points. To compare the number of intracellular bacteria without and with PGN at all other time points in the macrophage assays, a paired t-test was used. Statistical analysis was performed using Prism version 6.0 (GraphPad), and P < 0.05 was considered significant. Individual P values are reported. Multinomial probability was calculated to compare the expected frequency of outcomes with observed outcomes for strain ratios within individual abscesses in murine liver.
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Sample size
Sample sizes were predetermined for mouse and zebrafish experiments based on previous experimental data. The refined murine sepsis model, augmenting S. aureus sepsis with PG, increased reproducibility and decreased the spread of results. Revised power calculations (80% power; 95% confidence) permitted comparisons with 5 animals per group (n=5) for both weight loss (10% difference) and liver CFU (2 log difference).
Data exclusions In instances of unexpected death in animals which had otherwise been showing normal health, animals were excluded from analysis as per pre-established criteria.
Replication
All methods are described in the manuscript in order to allow replication of results. All attempts at replication were successful.
Randomization Mice were randomly selected for experimental or control groups and kept in separate cages throughout the experiment.
Blinding
Animal experiments were not blinded but to reduce bias, selected experiments were performed by different team researchers.
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